Appropriate use of screening and diagnostic tests to foster high-value, cost-conscious care
- PMID: 22250146
- DOI: 10.7326/0003-4819-156-2-201201170-00011
Appropriate use of screening and diagnostic tests to foster high-value, cost-conscious care
Abstract
Unsustainable rising health care costs in the United States have made reducing costs while maintaining high-quality health care a national priority. The overuse of some screening and diagnostic tests is an important component of unnecessary health care costs. More judicious use of such tests will improve quality and reflect responsible awareness of costs. Efforts to control expenditures should focus not only on benefits, harms, and costs but on the value of diagnostic tests-meaning an assessment of whether a test provides health benefits that are worth its costs or harms. To begin to identify ways that practicing clinicians can contribute to the delivery of high-value, cost-conscious health care, the American College of Physicians convened a workgroup of physicians to identify, using a consensus-based process, common clinical situations in which screening and diagnostic tests are used in ways that do not reflect high-value care. The intent of this exercise is to promote thoughtful discussions about these tests and other health care interventions to promote high-value, cost-conscious care.
Comment in
-
High-value testing begins with a few simple questions.Ann Intern Med. 2012 Jan 17;156(2):162-3. doi: 10.7326/0003-4819-156-2-201201170-00016. Ann Intern Med. 2012. PMID: 22250151 No abstract available.
-
Fostering high-value, cost-conscious care.Ann Intern Med. 2012 Jun 19;156(12):902; author reply 903-4. doi: 10.7326/0003-4819-156-12-201206190-00017. Ann Intern Med. 2012. PMID: 22711088 No abstract available.
-
Re: Appropriate use of screening and diagnostic tests to foster high-value, cost-conscious care.Ann Intern Med. 2012 Jun 19;156(12):902; author reply 903-4. doi: 10.7326/0003-4819-156-12-2201206190-00018. Ann Intern Med. 2012. PMID: 22711089 No abstract available.
-
Re: Appropriate use of screening and diagnostic tests to foster high-value, cost-conscious care.Ann Intern Med. 2012 Jun 19;156(12):902-3; author reply 903-4. doi: 10.7326/0003-4819-156-12-201206190-00019. Ann Intern Med. 2012. PMID: 22711090 No abstract available.
-
Re: Appropriate use of screening and diagnostic tests to foster high-value, cost-conscious care.Ann Intern Med. 2012 Jun 19;156(12):903; author reply 903-4. doi: 10.7326/0003-4819-156-12-201206190-00020. Ann Intern Med. 2012. PMID: 22711091 No abstract available.
Similar articles
-
Re: Appropriate use of screening and diagnostic tests to foster high-value, cost-conscious care.Ann Intern Med. 2012 Jun 19;156(12):903; author reply 903-4. doi: 10.7326/0003-4819-156-12-201206190-00020. Ann Intern Med. 2012. PMID: 22711091 No abstract available.
-
Re: Appropriate use of screening and diagnostic tests to foster high-value, cost-conscious care.Ann Intern Med. 2012 Jun 19;156(12):902-3; author reply 903-4. doi: 10.7326/0003-4819-156-12-201206190-00019. Ann Intern Med. 2012. PMID: 22711090 No abstract available.
-
Re: Appropriate use of screening and diagnostic tests to foster high-value, cost-conscious care.Ann Intern Med. 2012 Jun 19;156(12):902; author reply 903-4. doi: 10.7326/0003-4819-156-12-2201206190-00018. Ann Intern Med. 2012. PMID: 22711089 No abstract available.
-
Computerised decision support systems in order communication for diagnostic, screening or monitoring test ordering: systematic reviews of the effects and cost-effectiveness of systems.Health Technol Assess. 2010 Oct;14(48):1-227. doi: 10.3310/hta14480. Health Technol Assess. 2010. PMID: 21034668 Review.
-
High value, cost-conscious care: an international imperative.Eur J Intern Med. 2012 Sep;23(6):495-8. doi: 10.1016/j.ejim.2012.03.006. Epub 2012 Mar 28. Eur J Intern Med. 2012. PMID: 22863424 Review.
Cited by
-
Identifying antinuclear antibody positive individuals at risk for developing systemic autoimmune disease: development and validation of a real-time risk model.Front Immunol. 2024 Mar 20;15:1384229. doi: 10.3389/fimmu.2024.1384229. eCollection 2024. Front Immunol. 2024. PMID: 38571954 Free PMC article.
-
Framework for Classifying Explainable Artificial Intelligence (XAI) Algorithms in Clinical Medicine.Online J Public Health Inform. 2023 Sep 1;15:e50934. doi: 10.2196/50934. eCollection 2023. Online J Public Health Inform. 2023. PMID: 38046562 Free PMC article.
-
Assessing trainee critical thinking skills using a novel interactive online learning tool.Med Educ Online. 2023 Dec;28(1):2178871. doi: 10.1080/10872981.2023.2178871. Med Educ Online. 2023. PMID: 36871259 Free PMC article.
-
Choosing which in-hospital laboratory tests to target for intervention: a scoping review.Clin Chem Lab Med. 2022 Nov 22;61(3):388-401. doi: 10.1515/cclm-2022-0910. Print 2023 Feb 23. Clin Chem Lab Med. 2022. PMID: 36410390 Free PMC article. Review.
-
Assessing Bias and Limitations of Clinical Validation Studies of Molecular Diagnostic Tests for Indeterminate Thyroid Nodules: Systematic Review and Meta-Analysis.Thyroid. 2022 Oct;32(10):1144-1157. doi: 10.1089/thy.2022.0269. Epub 2022 Sep 26. Thyroid. 2022. PMID: 35999710 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical